Trending Topics

Cuba Exports Health Solutions and Technologies Across the World

heberprot-p2HAVANA, Cuba (ACN) — More than 50 nations buy Cuban medicines and technologies, one of the country’s main export items, said Victor Faife Perez, head of the department of pharmaceutical services in the ministry of public health.

The products include 30 drugs made only in Cuba and a group of generic ones that are bought by state members of the Bolivarian Alliance for the Peoples of Our America (ALBA) and nations in Asia, Africa and even Europe, said the official, quoted by the Juventud Rebelde newspaper.

Meanwhile, Gustavo Sierra Gonzalez, VP of BioCubaFarma reported also that they export technologies and diagnostic equipment that allow early detection of congenital malformations, hereditary diseases and other conditions.

He highlighted the creation for intensive care units, of equipment capable of measuring the proportions of gases in breathing in critically ill patients, which is very important in deciding the type of treatment they are to receive and save their lives.

Sierra Gonzalez said Cuba has manufacturing plants in various continents and the products that do well in these markets, including hearing aids.

“For cancer treatment, we increase the use of stimulants and vaccines to awaken the body’s own defence and make that be the main weapon to fight the tumour without resorting to a large extent, to chemotherapy, radiation and large surgeries,” he said.



What people are saying

2 thoughts on “Cuba Exports Health Solutions and Technologies Across the World

  1. Ron Brydges says:

    Cuba has a sizeable bio-tech industry from which they developed a treatment Heberprot-P that eliminates the necessity to amputate limbs in severe diabetes patients.

    Over 81,000 with diatetes worldwide treated with Cuban drug Heberprot-P. 2012-09-14 13:23:22 RSS Feedback Print Copy URL More.
    HAVANA, Sept. 13 (Xinhua) — Over 81,000 people with diabetes from 20 countries have been treated with the Cuba-developed drug Heberprot-P.

    The drug is considered to date as the only option to avoid the limb amputation in diabetic terminal lesions, an expert said here Thursday.

    Dr. Manuel Raices, specialist from the International Centre for Genetic Engineering and Biotechnology (ICGEB), said in a press conference that several years after its release, the Heberprot-P has shown high effectiveness in healing diabetic ulcers.

    The treatment with this drug has meant a revolution in handling with diabetic foot ulcers, which leads to an irreversible amputation, Dr Raices highlighted.

    According to U.S. statistics quoted by Cuban health officials, 65 percent of patients with foot ulcers certainly suffer amputation, with an accompanying treatment costing from 60,000 to 70,000 U.S. dollars.

    The use of this drug has become widespread with good results in Cuba since 2009 in about 100 health institutions, where thousands of patients were treated.

    The ICGEB expert recalled that Heberprot-P was submitted to a long process of research and testing before validating its results.

    He advanced that nano reasearch is being undertaken with the drug, aiming to obtain generations of that product more effective and with lower cost.

    Currently the Heberprot-P is available in 43 hospitals and 197 polyclinics in Cuba.

    With the purpose of promoting and expanding the use and trade of the Heberprot-P, Cuba will hold the International Congress Heberprot-P 2012, from Dec. 12 to 14 in Havana.

  2. Cuba is a beacon of hope for the world and a huge contrast to the imperialism and white supremacy that is the hallmark of U.S. policy.

Leave a Reply

Back to top